Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases May 14, 2024 Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress May 13, 2024 Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock May 2, 2024 Incyte to Present at Upcoming Investor Conference All press releases Latest Events May 15 2024 May 15 2024 BofA Securities Health Care Conference Click here for Webcast Apr 30 2024 Apr 30 2024 Q1 2024 Incyte Corporation Earnings Conference Call Click here for Webcast All events